Search

everythinglearnresearchcommunity

for

Search:↓

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Androgens affect the function and health of the endometrium.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

DHEA supplementation may improve quality of life, neuropsychological functions, and sexual satisfaction in individuals with adrenal insufficiency, but more research is needed to confirm its safety and effectiveness.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Non-compliance with PCOS medication worsens symptoms and highlights the need for better patient support and education.